This review discusses the overlap between screening for G6PD deficiency in newborns and testing for G6PD deficiency to inform malaria case management as well as the availability of new technologies that can bring G6PD testing to underserved and remote populations where G6PD deficiency and P. vivax malaria predominates. The gene discussed is G6PD; the disease is G6PD deficiency.